<scp>NCRI</scp> phase <scp>II</scp> study of <scp>CHOP</scp> in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndromeToby A. Eyre, Anna Schuh, Maité Cabes et al.|British Journal of Haematology|2016Cited by 66
Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicityToby A. Eyre, Chris S.R Hatton, Carolyn Mercer et al.|British Journal of Haematology|2019Cited by 65